DWac have been shown to attenuate TNBS- and DSS-induced colitis, as well as collagen-induced arthritis in mice by inhibiting the NF-κB signaling pathway and correcting Th17/Treg disturbance in vivo. This evidence concerns the gene NFKB1 and arthritic joint disease.